Clinical trials recruiting in Rostov-on-Don, Russia

Phase breakdown

Conditions recruiting in Rostov-on-Don, Russia

Recruiting trials in Rostov-on-Don, Russia

• A Long-term Extension Study of PCI-32765 (Ibrutinib)
  NCT01804686 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
  NCT07108309 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: Female
• Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
  NCT07078994 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
  NCT07164183 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female
• Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
  NCT06472310 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
  NCT06521229 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
  NCT07251023 · Phase: Phase 3 · Ages: 60 Years to 90 Years · Sex: All (male and female)
• Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
  NCT06930859 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female)
• ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia
  NCT07399665 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
  NCT07080034 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
  NCT03945968 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Rostov-on-Don, Russia?

11 recruiting trials have at least one study site in Rostov-on-Don, Russia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.